Interview Interview Expert talks and scientific presentations by local and international clinicians and scientists. Published: Apr 23, 2019

Precision medicine in Alzheimer’s disease: Where are we now and where are we going?

Dr Isaacson describes that a person’s genes and individual biology should be taken into account to better personalize care for Alzheimer’s disease.

Dr Isaacson has received honorarium/consultation fees from Neurotrack.

Learn more

Dementia Genetics cognition prevention anthropometrics precision medicine Diet risk factors Alzheimer’s disease VITACOG study blood-based biomarkers SPRINT MIND study